Physician profile
Dane A Ulett
NPI 1992767594
$5,424.44
in general payments reported to CMS, 2019-2025
26 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 86% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $80.49 · 2021: $768 · 2022: $602 · 2023: $973 · 2024: $987 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,404.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,233.55 | 2019-2025 | Stravix, Grafix, Grafix Xc |
| Treace Medical Concepts, INC. | $422.69 | 2022-2025 | |
| Medical Device Business Services, INC. | $348.12 | 2021 | |
| Averitas Pharma INC. | $302.60 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $250.49 | 2021-2022 | |
| Paragon 28, INC. | $192.46 | 2019-2024 | Monkey Rings, Portfolio |
| Bone Support INC. | $154.86 | 2024 | Cerament G, Ceramentbone Void Filler |
| Heron Therapeutics, INC. | $63.83 | 2021-2022 | |
| Melinta Therapeutics, LLC | $52.88 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $45.72 | 2024 | Nuzyra |
| Organogenesis INC. | $38.82 | 2023-2025 | Puraply Wound Matrix, Puraply |
| Integra Lifesciences Corporation | $33.73 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $32.40 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bioventus LLC | $29.60 | 2020 | |
| Merck Sharp & Dohme LLC | $27.83 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $26.06 | 2022 | |
| Lundbeck LLC | $25.40 | 2023 | Rexulti |
| Stryker Corporation | $22.37 | 2022 | |
| Mckesson Patient Care Solutions INC. | $18.23 | 2019 | |
| Horizon Therapeutics Plc | $17.98 | 2019 | |
| Nevro Corp. | $17.08 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.72 | 2021 | |
| Solventum Corporation | $15.79 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Convatec INC. | $12.83 | 2023 | |
| Depuy Synthes Sales INC. | $11.52 | 2021 | |
| Ets Wound Care LLC | $10.88 | 2025 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Ulett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.